Concord Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Concord Biotech Ltd. on BSE

Search Inside the pdf :

Concord Biotech Ltd.

27 May 2025, 09:38AM

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Revised Earning call Intimation. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, we wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Audited Standalone and Consolidated Financial Results of the Company for the Fourth quarter and year ended 31st March, 2025, scheduled on Friday, 30th May, 2025 at 02:30 P.M. IST. The Earnings Call invite is enclosed for your records.

pdf

Concord Biotech Ltd.

26 May 2025, 03:59PM

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, we wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Audited Standalone and Consolidated Financial Results of the Company for the Fourth quarter and year ended 31st March, 2025, scheduled on Friday, 30th May, 2025 at 04:00 P.M. IST.

pdf

Concord Biotech Ltd.

23 May 2025

1578.70

2.73%

Board Meeting

Concord Biotech Ltd - 543960 - Board Meeting Intimation for Approval Of Audited Financial Statements For …

BSE India

Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve the audited Standalone and Consolidated Financial results of the company for the quarter and year ended March 31, 2025

pdf

Concord Biotech Ltd.

13 May 2025

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

Pursuant to Reg 30 of the SEBI(LODR) 2015, this is to inform that CS Prakash Sajnani, vide letter dated 13/05/2025, has tendered his resignation from the post of Company Secretary and compliance officer with effect from 29/05/2025 after closure of working hours.

pdf

Concord Biotech Ltd.

02 May 2025

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Completion Of Inspection By United States Food And Drug Administration …

BSE India

The Company has announced the completion of the United States Food and Drug Administration (USFDA) inspection of our API facility at Dholka. The Inspection took place from April 28 to May 2, 2025.

pdf

Concord Biotech Ltd.

09 Apr 2025

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Enclosed herewith the certificate under regulation 74(5) of the SEBI(DP) Regulation,2018 for the quarter ended 31.03.2025.

pdf

Concord Biotech Ltd.

08 Apr 2025

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Disclosure Under Of SEBI (LODR) Regulations, 2015 'Concord Biotech Secures …

BSE India

The company has been granted final approval from the USFDA for marketing its Teriflunomide tablets 7mg and 14mg

pdf

Concord Biotech Ltd.

25 Mar 2025

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Commencement Of Commercial Production At Unit-4, Valthera

BSE India

Enclosed herewith announcement about successfully commissioned and commenced production of Injectable at our Manufacturing facility situated at Valthera.

pdf

Concord Biotech Ltd.

22 Mar 2025

1578.70

2.73%

SAST

Concord Biotech Ltd - 543960 - Closure of Trading Window

BSE India

The Trading window for dealing in securities of the company will be closed for all designated person and their immediate relatives with effect from 1st April, 2025 and the same will remain closed till 48 hours after the announcement of Audited financial results for month and quarter ended on 31st March, 2025. Kindly take on records.

pdf

Concord Biotech Ltd.

18 Mar 2025

1578.70

2.73%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 21st March 2025 in New york, USA.

pdf